EFEKTIVITAS DOSIS KARBON TETRAKLORIDA (CCl4) TERHADAP TIKUS (Rattus norvegicus L.) SEBAGAI HEWAN MODEL FIBROSIS HATI

Fahri Fahrudin, Sri Ningsih, Hajar Indra Wardhana, Dinda Rama Haribowo, Fathin Hamida
10.14203/beritabiologi.v19i3B.3961
| Abstract views: 5333 | PDF views: 4007

Abstract

Liver damage can produce fibrosis condition both acute and chronic. Development of liver fibrosis in animal models is valuable information in order to gain new entities for treatment. The aim of this study is to get an optimal condition of CCl4 induction for achieving animal
models of liver fibrosis. CCl4 diluted in coconut oil was administrated orally for 6 consecutive weeks. Total 25 male rats were divided into 5 treatment groups, namely, P1 was a normal group (without CCl4). P2 (CCl4 40%), 1 ml/kg bw 3 times a week. P3 (CCl4 40%), 0.5 ml/kg bw 3 times a week, P4 (CCl4 10%) 1 ml/kg bw 3 times a week, and P5 (CCl4 10%) 1 ml/kg bw twice a week. The analyzed parameters were the activity of liver enzymes, macro and microscopic liver damage, and the percentage of rat deaths. The results of this study indicated an increase in liver enzymes in all treatments which was higher than P1 (P<0.05). Analysis of liver histopathology exhibeted the same result. However, if viewed the percentage of rat deaths, P5 demonstrated the lowest compared to all treatment groups. It could be concluded  that the administration of CCl4 (10%) was able to create an animal model of liver fibrosis optimally.

 

 

Keywords

animal model, liver fibrosis, liver enzymes, rat, CCl4

Full Text:

PDF

References

Arafah, E., 2005. Perlindungan dan efek penyembuhan sediaan bangle (Zingiber cassumunor Roxb.) terhadap peradangan hati tikus serta mekanismenya pada sel makrofag dan limfosit. Disertasi. Bogor (ID): Institut Pertanian Bogor.

Bataller, R., North, K.E. and Brenner, D.A., 2003. Genetic

polymorphisms and the progreeion of liver fibrosis: a critical appraisal. Hepatology, 37, pp. 493–503. doi:10.1053/jhep. 2003.50127.

Bataller, R. and Brenner D.A., 2005. Liver Fibrosis. Journal of Clinical Investigation, 115, pp. 209–218. doi:10.1172/ JCI200524282.

Boll, M., Weber, L.W.D., Becker, E. and Stampfl, A., 2001.

Mechanism of Carbon Tetrachloride-Induced Hepatotoxicity: Hepatocellular Damage by Reactive Carbon Tetrachloride Metabolites. Naturforsch, 56, pp. 649–659.

Devi, S.L., Viswanathan, P. and Anuradha, C.V., 2010. Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation. European Journal of Pharmacology, 647, pp. 161–170. doi:10.1016/j.ejphar. 2010.08.011.

Di Sario, A., Bendia, E., Macarri, G., Candelaresi, C., Taffetani, S., Marzioni, M., Omenetti, A., De Minicis, S., Trozzi, L. and Benedetti, A., 2004. The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen α1(I), TIMP-1 and MMP-2. Digestive and liver Disease. 36, pp. 744–751.doi:10.1016/j.dld.2004.05.012.

Edward, Z., 2009. The function utilization of gambier (Uncaria gambir) as the hepatoprotector. J. Ris.Kim. 2(2), pp. 1–7.

Foo, N.P., Lin, S.H., Lee, Y.H., Wu, M.J. and Wang, Y.J., 2011. Α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β. Toxicology. 282, pp. 39–46. doi:10.1016/j.tox. 2011.01.009.

Gagne, J.M., Weiss, D.J. and Amstrong, P.J., 1996. Histopatologic evaluation of feline inflammatory liver disease. Veterinary Pathology, 33, pp. 521–526.

Gerling, B., Becker, M., Waldschmidt, J., Rehmann, M. and Schuppan, D., 1996. Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis. Journal of Hepatology, 25, pp. 79–84.

Ghatak, S., Biswas, A., Dhali, G.K., Chowdhury, A., Boyer, J.L. and Santra, A., 2011. Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice. Toxicology and Applied Pharmacology, 251, pp. 59–69.

Hubscher, S.G., 2006. Histological assessment of non-alcoholic fatty liver disease. Histopathology, 49, pp. 450–456. doi:10.1111/j.1365-2559-2006.0241.6.x.

Humason, G.L., 1972. Animal Tissue Techniques. 3nd Edition. San Fransisco: W. H. Freeman and Company. pp. 173–177.

Inoue, T., Ando, K. and Kikugawa, K., 1998. Specific determination of malonaldehyde by n-methil-2-phenylindole or thiobarbituric acid. JAOCS, 75(5), pp. 597–600.

Jeon, T.I., Hwang, S.G., Park, N.G., Jung, Y.R., Shin, S.I., Choi, S.D. and Park, D.K., 2003. Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology, 187, pp. 67–73.doi:10.1016/S0300-483X(03)00003-9.

Khan R.A., Khan M.R., Ahmed M., Sahreen S., Shah N.A., Shah M.S., Bokhari J., Rashid U., Ahmad B. and Jan S. 2012. Hepatoprotection with a chloroform extract of Launaea procumbens against CCl4-induced injuries in rats. BMC Complementary and Alternative Medicine, 12, p. 114.

Kiernan, J.A., 2008. Histological and Histochemical Methods. Theory and Practice. 4th Edition. Canada: Pergamon Press. pp. 90–97.

Ko, W.S., Hsu, S.L., Chyau, C.C., Chen, K.C. and Peng, R.Y., 2010. Compound cordyceps TCM-700C exhibits potent hepatoprotective capability in animal model. Fitoterapia, 81, pp. 1–7. doi:10.1016/j.fitote.2009. 06.018.

Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P. and Mukhrejee, P.K., 2006. Curcumin-phospolipid complex: preparation, therapeutic ecaluation and pharmacokinetic study in rats. International Journal of Pharmaceutics, 330, pp. 155–163. doi:10.1016/j.ijpharm.2006.09. 025.

Mansour, H.H., Hafez, H.H. and Fahmy, N.M., 2006. Silymarin modulates cisplatin-induced oxidative stress and hepatoxicity in rats. Journal of Biochemistry and Molecular Biology, 39(6), pp. 656–661.

Merat, S., Sameni, F.K., Nouraie, M., Derakhsan, M.H., Tavangar, S.M. and Mossaffa, S., 2010. A modification of the brunt system for scoring liver histology of patients with non-alcoholic fatty liver disease. Archives of Iranian Medicine, 13(1), pp. 38–44.

Panjaitan, R.G.P., 2008. Pengujian aktivitas hepatoprotektor akar pasak bumi (Eurycoma longifolia Jack.) Disertasi. Bogor (ID): Institut Pertanian Bogor.

Presnell, M.J. and Schreibman, M.P., 1997. Humason’s Animal Tissue Techniques.5th Edition. Canada: Johns Hopkins University Press. pp. 173–177.

Tang, L.X., He, R.H., Yang, G., Tan, J.J., Zhou, L., Meng, X.M., Huang, X.R. and Lan, H.Y., 2012. Asiatic acid inhibits liver fibrosis by blocking TGF-β/smad signaling in vivo and in vitro. PlosONE, 7(2), p.e31350. doi:10.1371/journal.pone.0031350.

Venukumar, M.R. and Latha, M.S., 2002. Hepatoprotective effect of the methanolic of Curculigo orchioides in CCl4-treated male rats. Indian Journal of Pharmacology, 34, pp. 269–275.

Weber, L.W.D., Boll, M. and Stampfl, A., 2003. Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as A Toxicological model. Toxicology, 33(2), pp. 105–1036.

Zainuri, M. dan Wanandi, S.I., 2012. Aktivitas spesifik manganese superoxide dismutase (MnSOD) dan katalase pada hati tikus yang diinduksi hipoksia sistemik: hubungannya dengan kerusakan oksidatif. Media Litbang Kesehatan, 22(2), pp. 87–92.

DOI: https://doi.org/10.14203/beritabiologi.v19i3B.3961

Refbacks

  • There are currently no refbacks.